Novel acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase

作者: Siao-Jhen Chen , Hsun-Yin Hsu , Kai-Ping Chen , Yi-Jen Yech , Chiao-Ming Liao

DOI:

关键词:

摘要: A method for inhibiting xanthine oxidase and reducing uric acid levels using a pharmaceutical composition or food product obtained by culturing Gluconacetobacter hansenii Acetobacter pasteurianus in medium. Also disclosed is that each include metabolite of subject methods producing the product.

参考文章(22)
Elvira A Falco, George H Hitchings, Treatment of hyperuricemia in humans ,(1967)
Thomas Mintus, Michael Hahn, Water-soluble coffee preparations ,(2014)
William R Peterson, Walter N Johnson, Carboxylated graft copolymer and emulsion containing same ,(1973)
Akina Satou, Noriko Kaneko, Hiroshi Tsuboi, Katsunori Kimura, Akinori Kume, Lactic acid bacterium having effect of lowering blood uric acid level ,(2008)
John M. Eddington, Hungming J. Liaw, Yuequin Yang, Robert L. Kowzic, Bacterial strains and fermentation processes for the production of 2-keto-l-gulonic acid ,(2000)
Maria Altamura, Alberto Aleotti, Carlo Alberto Maggi, Pharmaceutical compositions based on nk2 antagonists for pediatric use ,(2005)
Akina Satou, Noriko Kaneko, Hiroshi Tsuboi, Yoshinobu Tsuchiya, Lactic acid bacteria having action of lowering blood uric acid level ,(2007)
HITOSHI IZUMIDA, KYOKO ADACHI, AKIRA MIHARA, TOHRU YASUZAWA, HIROSHI SANO, Hydroxyakalone, a Novel Xanthine Oxidase Inhibitor Produced by a Marine Bacterium, Agrobacterium aurantiacum The Journal of Antibiotics. ,vol. 50, pp. 916- 918 ,(1997) , 10.7164/ANTIBIOTICS.50.916